13 studies found for: Open Studies | "Carcinoma, Islet Cell"
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
|2||Not yet recruiting||
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Pazopanib in Treating Patients With Advanced Neuroendocrine Cancer
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome
Nexium Capsules Clinical Experience Investigation
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
† Indicates status has not been verified in more than two years